Discover more

Wendy Wilkinson

Mrs Wendy Wilkinson qualified as a diagnostic radiographer in 1980 and worked in both the NHS and independent sector in a range of diag

Wendy Wilkinson

Mrs Wendy Wilkinson qualified as a diagnostic radiographer in 1980 and worked in both the NHS and independent sector in a range of diagnostic radiography roles across various modalities in secondary care and tertiary centres.

Professor Erika Denton

Erika is a consultant radiologist and was Medical Director in Norwich from 2018 to 2023. She was the National Medical Director 2023 to 2025 in the Transformation Directorate including clinical leadership of digital programmes, artificial intelligence, research and pathway transformation.

Amy Eccles

Dr Amy Eccles is a Radionuclide Radiologist specialising in oncological radionuclide therapy and imaging. Her therapy interests include treatment of prostate cancers using Radium223 di-chloride and Lutetium 177-PSMA and Lutetium 177-DOTATATE treatment of neuroendocrine tumours. She reports both oncological and non-oncological PET/CT imaging using FDG and non FDG tracers as well as conventional CT.

Amy Eccles

Dr Amy Eccles is a Radionuclide Radiologist specialising in oncological radionuclide therapy and imaging. Her therapy interests include treatment of prostate cancers using Radium223 di-chloride and Lutetium 177-PSMA and Lutetium 177-DOTATATE treatment of neuroendocrine tumours. She reports both oncological and non-oncological PET/CT imaging using FDG and non FDG tracers as well as conventional CT.

Dr Teik Choon See

Dr See is a Consultant Interventional Radiologist at Cambridge University Hospitals NHS Foundation Trust (CUH). He has varied experience in service delivery, patient safety, education and research.

Amy Eccles

Dr Amy Eccles is a Radionuclide Radiologist specialising in oncological radionuclide therapy and imaging. Her therapy interests include treatment of prostate cancers using Radium223 di-chloride and Lutetium 177-PSMA and Lutetium 177-DOTATATE treatment of neuroendocrine tumours. She reports both oncological and non-oncological PET/CT imaging using FDG and non FDG tracers as well as conventional CT.